Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/17/2007CN100342847C Stomach nourishing dispersible tablet with aucklandia root and amomum fruit and its preparation method
10/17/2007CN100342846C Compression molded product and production method therefor
10/17/2007CN100342845C Moisture-proof coating method for Chinese medicine granule
10/16/2007US7282578 Having at least one intron sequence; constructs and host cells; expression product and antibodies obtainable by immunization of an animal therewith, as well as the use of antibodies in screening methods for the identification of tumors
10/16/2007US7282489 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia
10/16/2007US7282486 A dosage form of pure crystalline azithromycin monohydrate hemi-ethanol solvate and a carrier or diluent; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of humans, mammals, birds and fish; drug resistance
10/16/2007US7282358 Monochromatic fluid treatment systems
10/16/2007US7282221 Dosage forms of antiviral and a carrier; an immediate release dosage form and delayed release dosages, each initiates release at different times; product contains the total dosage of the antiviral for a twenty-four hour period
10/16/2007US7282220 Administering heparin which is encapsulated within a gelatin carrier
10/16/2007US7282219 Medicine of high molecular weight such as insulin and a cationic polymer such as aminoalkyl methacrylate copolymer, the preparation further comprising at least one kind of basic amino acid or salt
10/16/2007US7282218 Pharmaceutical composition; hydrophobic monomer, a basic monomer, a hydrophilic monomer and an amorphous form of a bitter drug within the polymer matrix; inhibits the crystallization of the drug during formulation and reconstitution
10/16/2007US7282217 Rapidly disintegrable tablets
10/16/2007US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery
10/16/2007US7282215 Supports for photosensitizer formulations
10/16/2007US7282214 Biomedical devices with antimicrobial coatings
10/16/2007US7282195 comprises non-oil natural/artificial flavoring agent, ultraviolet light absorber, curing system, and filler; for repairing/protecting teeth
10/16/2007US7282194 Nanoparticles for protein drug delivery
10/16/2007US7282045 Ingestible device
10/16/2007US7281641 Stackable low depth tray
10/16/2007CA2538996C External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
10/16/2007CA2336654C Plaster which contains steroids, and a method for the production and use thereof
10/16/2007CA2248087C Improved vision through photodynamic therapy of the eye
10/16/2007CA2237699C Novel protein complexes
10/16/2007CA2214026C Pharmaceutical compositions comprising monoamine oxidase b inhibitors
10/16/2007CA2159609C Factor xiii for treatment of skin wounds
10/16/2007CA2114250C Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases
10/11/2007WO2007115305A2 Oral dosage forms including an antiplatelet agent and an acid inhibitor
10/11/2007WO2007115147A2 Thermometer
10/11/2007WO2007115146A2 Protection against charging damage in hybrid orientation transistors
10/11/2007WO2007115143A2 Dead spindle pto with compliant grounding mechanism
10/11/2007WO2007115135A2 Aircraft passenger seat
10/11/2007WO2007115043A2 Valves having corrosion resistant ceramic coating
10/11/2007WO2007114977A2 Lithium-metal-oxide composite electrodes
10/11/2007WO2007114921A2 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5] decan-2-one and treatment methods using the same
10/11/2007WO2007114898A1 Film-coated solid dosage forms
10/11/2007WO2007114881A1 Technology for preparation of macromolecular microspheres
10/11/2007WO2007114797A1 Porous tablets for subsequent filling with active pharmaceutical ingredient
10/11/2007WO2007114380A1 Agent for external application to the skin
10/11/2007WO2007114376A1 Solid pharmaceutical preparation
10/11/2007WO2007114315A1 Therapeutic agent for corneal/conjunctival disorder
10/11/2007WO2007114301A1 Stabilizer for composition containing water-soluble polymer thickener
10/11/2007WO2007114262A1 Casein nanoparticle
10/11/2007WO2007114128A1 Method for production of capsinoid-containing beverage/food
10/11/2007WO2007114013A1 Composition containing lignan compound
10/11/2007WO2007113857A2 Modified release clopidogrel formulation
10/11/2007WO2007113762A2 Bulking of soft tissue
10/11/2007WO2007113665A2 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides
10/11/2007WO2007113536A1 A tablet of paracetamol containing an encapsulated flavorant
10/11/2007WO2007113454A1 Particulate compositions comprising alginate and/or alginic acid
10/11/2007WO2007113371A1 Pharmaceutical composition and preparation method thereof
10/11/2007WO2007113207A2 Coated formulations
10/11/2007WO2007113187A1 Oral pharmaceutical coated composition for pulsatile release
10/11/2007WO2007113008A2 Opaque container comprising food or pharmaceutical products or herbal(s)
10/11/2007WO2007112986A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
10/11/2007WO2007112967A1 Process for the preparation of water-in-oil and oil-in-water nanoemulsions
10/11/2007WO2007112750A2 Tablets and capsules comprising immunogens for oral administration
10/11/2007WO2007112747A1 Immunogen combinations
10/11/2007WO2007112619A1 Oseltamivir phosphate granule and preparation mehtod thereof
10/11/2007WO2007112581A1 Controlled release delivery device comprising an organosol coat
10/11/2007WO2007112579A1 Drug delivery composition
10/11/2007WO2007112574A1 Extended release composition of venlafaxine
10/11/2007WO2007112567A1 Synthetic archaeal glycolipid adjuvants
10/11/2007WO2007098128A3 Phenylephrine-containing liquid formulations
10/11/2007WO2007078271A3 Lansoprazole orally disintegrating tablets
10/11/2007WO2007073894A3 Oral preparation with controlled release
10/11/2007WO2007072380A3 Method of making dried particles
10/11/2007WO2007070632A3 Abuse resistant transmucosal drug delivery device
10/11/2007WO2007057714A3 Pharmaceutical compositions comprising methotrexate
10/11/2007WO2007053810A9 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, preparation, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
10/11/2007WO2007047994A3 Dental and endodontic filling materials and methods
10/11/2007WO2007047948A3 Intranasal administration of rapid acting insulin
10/11/2007WO2007041479A3 Pharmaceutical compositions
10/11/2007WO2007039122A3 Solid orally administerable pharmaceutical dosage forms with rapid active principle release
10/11/2007WO2007038802A3 Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
10/11/2007WO2007035336A3 Effervescent rehydrating beverage tablet/granules
10/11/2007WO2007024826A3 Method of storing nanoparticle formulations
10/11/2007WO2007022152A3 Lipid nano particulates containing antigens as cancer vaccines
10/11/2007WO2007016679A3 Combination immediate release controlled release levodopa and carbidopa dosage forms
10/11/2007WO2007014328A3 Compositions and methods for emulsifying a perfluorocarbon with an oxygen-carrying surfactant
10/11/2007WO2007010442A3 Method and system for in vivo drug delivery
10/11/2007WO2006112958A8 Methods and compositions for modified release of nutritional supplements
10/11/2007WO2006087177B1 Solid peroral contraceptive drug
10/11/2007WO2006084087A3 Compositions and methods for nutrition supplementation
10/11/2007US20070239139 Instructional medical treatment system
10/11/2007US20070238787 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
10/11/2007US20070238786 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238708 Acute Inflammatory Condition Treatment
10/11/2007US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007US20070238686 Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal-Antisense Oligodeoxy-Nucleotides Targeting To Grb2 or Crk1
10/11/2007US20070237871 Method for Producing Orally Administrable Edible Agent of Aggregated Substance-Containing Laminate Film Form and Orally Administrable Edible Agent of Aggregated Substance-Containing Laminate Film Form
10/11/2007US20070237856 Impact of calcium phosphate complex on dental caries
10/11/2007US20070237835 Peritoneal Dialysis Solution
10/11/2007US20070237833 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237832 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237831 Nanoparticles for monoclonal antibody delivery
10/11/2007US20070237830 for embolic treatment, treating uterine fibroids, and cancerous tumors; arteriovenous malformation
10/11/2007US20070237829 Melanin nanoshells for protection against radiation and electronic pulses
10/11/2007US20070237828 Ziprasidone Dosage Form